Literature DB >> 4405503

Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study.

M K el-Yousef, D Janowsky, J M Davis, H J Sekerke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4405503     DOI： 10.1176/ajp.130.2.141

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

1.  The management of neuroleptic-induced CNS effects.

Authors:  B F Hoffman; M V Seeman
Journal:  Can Fam Physician       Date:  1981-10       Impact factor: 3.275

2.  Experiences with physostigmine in the reversal of adverse post-anaesthetic effects.

Authors:  J Brebner; L Hadley
Journal:  Can Anaesth Soc J       Date:  1976-11

3.  On the interaction of drugs with the cholinergic nervous system. VI. Tolerance to physostigmine in mice.

Authors:  S Maayani; Y Egozi; I Pinchasi; M Sokolovsky
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

Review 4.  Acetylcholinesterase inhibitors for schizophrenia.

Authors:  Jasvinder Singh; Kamalpreet Kour; Mahesh B Jayaram
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

5.  Physostigmine reversal of postoperative somnolence.

Authors:  G E Hill; T H Stanley; C R Sentker
Journal:  Can Anaesth Soc J       Date:  1977-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.